vimarsana.com
Home
Live Updates
AstraZeneca Sees Double-Digit Growth for Core Earnings, Reve
AstraZeneca Sees Double-Digit Growth for Core Earnings, Reve
AstraZeneca Sees Double-Digit Growth for Core Earnings, Revenue in 2024 -- Update
By Elena Vardon AstraZeneca sees its revenue and core earnings per share growing by double-digit percentages in 2024, the pharmaceuticals major said as it...
Related Keywords
Sweden ,
London ,
City Of ,
United Kingdom ,
Swedish ,
Elena Vardon ,
Pascal Soriot ,
Astrazeneca ,
Executive Pascal Soriot ,
Article Normal ,
Biotechnology Services ,
Pharmaceuticals ,
Healthcare Life Sciences ,
Biopharmaceuticals ,
Financial Performance ,
Earnings ,
Corporate Industrial News ,
Content Types ,
Factiva Filters ,
C Amp Ampe Industry News Filter ,
Synd ,
Azn Ln ,
Uk Azn ,
Corporate ,
Industrial News ,
Healthcare ,
Life Sciences ,